359 related articles for article (PubMed ID: 12845304)
21. Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT.
Ding H; Kudo M; Onda H; Suetomi Y; Minami Y; Chung H; Kawasaki T; Maekawa K
Radiology; 2001 Dec; 221(3):721-30. PubMed ID: 11719668
[TBL] [Abstract][Full Text] [Related]
22. Contrast enhancement patterns of hepatic tumours during the vascular phase using coded harmonic imaging and Levovist to differentiate hepatocellular carcinoma from other focal lesions.
Furuse J; Nagase M; Ishii H; Yoshino M
Br J Radiol; 2003 Jun; 76(906):385-92. PubMed ID: 12814924
[TBL] [Abstract][Full Text] [Related]
23. Improved sonographic imaging of hepatic hemangioma with contrast-enhanced coded harmonic angiography: comparison with MR imaging.
Lee JY; Choi BI; Han JK; Kim AY; Shin SH; Moon SG
Ultrasound Med Biol; 2002 Mar; 28(3):287-95. PubMed ID: 11978408
[TBL] [Abstract][Full Text] [Related]
24. Hemangiomas and focal nodular hyperplasia images in contrast-enhanced, wide-band phase-inversion harmonic power Doppler imaging.
Janica J; Serwatka W; Polaków J; Ustymowicz A; Łebkowska U; Kordecki K; Walecki J; Polaków P; Dobrzycki S
Med Sci Monit; 2004 Jun; 10 Suppl 3():26-31. PubMed ID: 16538195
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of enhancement patterns of focal nodular hyperplasia in contrast-enhanced, wide-band phase-inversion harmonic power Doppler imaging of the liver.
Janica J; Serwatka W; Polaków J; Ustymowicz A; Walecki J; Ladny JR; Dobrzycki S
Med Sci Monit; 2004 Jun; 10 Suppl 3():17-21. PubMed ID: 16538193
[TBL] [Abstract][Full Text] [Related]
26. Application of superb microvascular imaging in focal liver lesions.
He MN; Lv K; Jiang YX; Jiang TA
World J Gastroenterol; 2017 Nov; 23(43):7765-7775. PubMed ID: 29209117
[TBL] [Abstract][Full Text] [Related]
27. Arterioportal shunt: prevalence in small hemangiomas versus that in hepatocellular carcinomas 3 cm or smaller at two-phase helical CT.
Byun JH; Kim TK; Lee CW; Lee JK; Kim AY; Kim PN; Ha HK; Lee MG
Radiology; 2004 Aug; 232(2):354-60. PubMed ID: 15215556
[TBL] [Abstract][Full Text] [Related]
28. Comparison of diagnostic performance of unenhanced vs SonoVue - enhanced ultrasonography in focal liver lesions characterization. The experience of three Italian centers.
Quaia E; Stacul F; Gaiani S; Ricci P; Passariello R; Curzio D; Pozzi Mucelli R
Radiol Med; 2004; 108(1-2):71-81. PubMed ID: 15269691
[TBL] [Abstract][Full Text] [Related]
29. Differentiation of hepatic tumors by color Doppler imaging: role of the maximum velocity and the pulsatility index of the intratumoral blood flow signal.
Kudo M; Tochio H; Zhou P
Intervirology; 2004; 47(3-5):154-61. PubMed ID: 15383724
[TBL] [Abstract][Full Text] [Related]
30. Contrast-enhanced ultrasound in combination with color Doppler ultrasound can improve the diagnostic performance of focal nodular hyperplasia and hepatocellular adenoma.
Kong WT; Wang WP; Huang BJ; Ding H; Mao F; Si Q
Ultrasound Med Biol; 2015 Apr; 41(4):944-51. PubMed ID: 25701530
[TBL] [Abstract][Full Text] [Related]
31. Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508A: early experience.
Blomley MJ; Albrecht T; Cosgrove DO; Patel N; Jayaram V; Butler-Barnes J; Eckersley RJ; Bauer A; Schlief R
Radiology; 1999 Feb; 210(2):409-16. PubMed ID: 10207423
[TBL] [Abstract][Full Text] [Related]
32. Enhanced color flows in hepatic tumors.
Yang CC; Chen CH; Yeh YH
Hepatogastroenterology; 2002; 49(48):1506-9. PubMed ID: 12397719
[TBL] [Abstract][Full Text] [Related]
33. Color doppler ultrasound of liver lesions: signal enhancement after intravenous injection of the ultrasound contrast agent Levovist.
Ernst H; Hahn EG; Balzer T; Schlief R; Heyder N
J Clin Ultrasound; 1996 Jan; 24(1):31-5. PubMed ID: 8655665
[TBL] [Abstract][Full Text] [Related]
34. Characterization of focal hepatic lesions with contrast-enhanced C-cube gray scale ultrasonography.
Wang WP; Ding H; Qi Q; Mao F; Xu ZZ; Kudo M
World J Gastroenterol; 2003 Aug; 9(8):1667-74. PubMed ID: 12918098
[TBL] [Abstract][Full Text] [Related]
35. Characterization of liver lesions by real-time contrast-enhanced ultrasonography.
Celli N; Gaiani S; Piscaglia F; Zironi G; Camaggi V; Leoni S; Righini R; Bolondi L
Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):3-14. PubMed ID: 17206071
[TBL] [Abstract][Full Text] [Related]
36. Corona enhancement in ultrasonographical post-vascular phase images with microbubble contrast agent: a novel specific sign for hepatocellular carcinomas.
Yamamoto K; Nakanishi S; Fuke H; Hashimoto A; Shimizu A; Hamataki T; Shiraki K
Oncol Rep; 2006 Apr; 15(4):785-90. PubMed ID: 16525659
[TBL] [Abstract][Full Text] [Related]
37. Liver lesions: intermittent second-harmonic gray-scale US can increase conspicuity with microbubble contrast material-early experience.
Heckemann RA; Cosgrove DO; Blomley MJ; Eckersley RJ; Harvey CJ; Mine Y
Radiology; 2000 Aug; 216(2):592-6. PubMed ID: 10924591
[TBL] [Abstract][Full Text] [Related]
38. Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images.
Karabacakoğlu A; Adigüzel Y; Karaköse S; Kayaçetin E; Haykir R
Turk J Gastroenterol; 2006 Sep; 17(3):164-71. PubMed ID: 16941248
[TBL] [Abstract][Full Text] [Related]
39. Contrast-enhanced ultrasonographic spoke-wheel sign in hepatic focal nodular hyperplasia.
Yen YH; Wang JH; Lu SN; Chen TY; Changchien CS; Chen CH; Hung CH; Lee CM
Eur J Radiol; 2006 Dec; 60(3):439-44. PubMed ID: 16916591
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the vascular architecture of focal liver lesions using micro flow imaging.
Yang H; Liu GJ; Lu MD; Xu HX; Xie XY
J Ultrasound Med; 2013 Jul; 32(7):1157-71. PubMed ID: 23804338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
